A detailed history of Twin Tree Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Twin Tree Management, LP holds 207,400 shares of ABBV stock, worth $38.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
207,400
Previous 201,800 2.78%
Holding current value
$38.1 Million
Previous $34.6 Million 18.33%
% of portfolio
0.08%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $2.98 Million - $3.39 Million
-18,639 Reduced 51.22%
17,753 $3.23 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $5.01 Million - $5.64 Million
36,392 New
36,392 $5.64 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $11.2 Million - $13.4 Million
81,058 New
81,058 $13.1 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $18.7 Million - $23.8 Million
-136,044 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $4.93 Million - $6.12 Million
37,347 Added 37.84%
136,044 $22.1 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $10.6 Million - $13.4 Million
98,697 New
98,697 $13.4 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $11 Million - $12.9 Million
-127,636 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $8.22 Million - $11 Million
111,998 Added 716.19%
127,636 $12.5 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $806,629 - $1.01 Million
11,183 Added 251.02%
15,638 $1.39 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $13.5 Million - $15 Million
-151,451 Reduced 97.14%
4,455 $421,000
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $7.15 Million - $8.46 Million
79,614 Added 104.35%
155,906 $14.4 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $6.63 Million - $8.88 Million
72,077 Added 1710.01%
76,292 $7.22 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $377,495 - $413,955
4,215
4,215 $408,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.